BioCentury | Oct 13, 2016
Distillery Therapeutics

Therapeutics: SRY-box 4 (SOX4); long non-coding RNA SRY box 4 (LNCSOX4)

...suggest inhibiting SOX4 or LNCSOX4 could help treat hepatocellular carcinoma (HCC). In HCC patients, high LNCSOX4...
...normal SOX3 and LNCSOX4 expression. In a patient-derived xenograft mouse model of HCC, knockdown of LNCSOX4...
...small molecule SOX4 orLNCSOX4 inhibitor in animal models of HCC. TARGET/MARKER/PATHWAY: SRY-box 4 (SOX4) ; long non-coding RNA SRY box 4 (LNCSOX4)...
Items per page:
1 - 1 of 1